Lipocalin-2 in Stroke.
Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Li-pocalin-2 (LCN2) is an acute phase protein mediating neuroinflammation after ischemic and hemorrhagic strokes. This review is an attempt to summarize some LCN2-related research findings and discuss its role in stroke.
['Chou|Wen-Hai|WH|', 'Wang|Guona|G|', 'Kumar|Varun|V|', 'Weng|Yi-Chinn|YC|']
Lipocalin-2 Stroke 24p3 Biomarker NGAL Neutrophil PKC Phosphorylation Reperfusion injury